UGT genomic diversity: beyond gene duplication

References

• Al-Romaih, K., Somers, G. R., Bayani, J., Hughes, S., Prasad, M., Cutz, J. C., et al. (2007). Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation. Cancer Cell Int 7:14.
   PubMedGoogle Scholar
• Anisimov, S. V. (2008). Serial analysis of gene expression (SAGE): 13 years of application in research. Curr Pharm Biotechnol 9:338–350.
   PubMed Web of Science ®Google Scholar
• Aono, S., Adachi, Y., Uyama, E., Yamada, Y., Keino, H., Nanno, T., et al. (1995). Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert’s syndrome. Lancet 345:958–959.
   PubMed Web of Science ®Google Scholar
• Aono, S., Yamada, Y., Keino, H., Hanada, N., Nakagawa, T., Sasaoka, Y., et al. (1993). Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 197:1239–1244.
   PubMed Web of Science ®Google Scholar
• Aueviriyavit, S., Furihata, T., Morimoto, K., Kobayashi, K., Chiba, K. (2007). Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3, and UGT1A4 mRNA in human livers. Drug Metab Pharmacokinet 22:391–398.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Turgeon, D., Girard, C., Green, M. D., Tephly, T. R., Hum, D. W., et al. (2000). 3’-azido-3’-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 28:497–502.
   PubMed Web of Science ®Google Scholar
• Beaulieu, M., Levesque, E., Hum, D. W., Belanger, A. (1996). Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855–22862.
   PubMed Web of Science ®Google Scholar
• Belanger, A., Hum, D. W., Beaulieu, M., Levesque, E., Guillemette, C., Tchernof, A., et al. (1998). Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 65(1–6):301–310.
   PubMed Web of Science ®Google Scholar
• Belanger, A., Pelletier, G., Labrie, F., Barbier, O., Chouinard, S. (2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473–479.
   PubMed Web of Science ®Google Scholar
• Belanger, A.S., Caron, P., Harvey, M., Zimmerman, P.A., Mehlotra, R.K,, Guillemette, C. (2009). Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. Drug Metab Dispos 37:1793–1796.
   PubMed Web of Science ®Google Scholar
• Bellemare, J., Rouleau, M., Harvey, M., Tetu, B., Guillemette, C. Alternative spliced forms of the major phase II conjugating UGT1A gene regulate glucuronidation in human carcinoma cell lines. In revision.
   Google Scholar
• Boeger, H., Bushnell, D. A., Davis, R., Griesenbeck, J., Lorch, Y., Strattan, J. S., et al. (2005). Structural basis of eukaryotic gene transcription. FEBS Lett 579:899–903.
   PubMed Web of Science ®Google Scholar
• Bonzo, J. A., Belanger, A., Tukey, R. H. (2007). The role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice. Hepatology 45:349–360.
   PubMed Web of Science ®Google Scholar
• Buckley, D. B., Klaassen, C. D. (2009). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847–856. [Epub 2009 Jan 14].
   PubMed Web of Science ®Google Scholar
• Burchell, B., Coughtrie, M. W. (1997). Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation. Environ Health Perspect 105(Suppl 4):739–747.
   PubMedGoogle Scholar
• Burchell, B., Soars, M., Monaghan, G., Cassidy, A., Smith, D., Ethell, B. (2000). Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases. Toxicol Lett 112–113:333–340.
   Google Scholar
• Chang, Y. F., Imam, J. S., Wilkinson, M. F. (2007). The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76:51–74.
   PubMed Web of Science ®Google Scholar
• Coffman, B. L., Rios, G. R., King, C. D., Tephly, T. R. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1–4.
   PubMed Web of Science ®Google Scholar
• Court, M. H. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104–116.
   PubMed Web of Science ®Google Scholar
• Court, M. H., Hazarika, S., Krishnaswamy, S., Finel, M., Williams, J. A. (2008). Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 74:744–754. [Epub 2008 June 3].
   PubMed Web of Science ®Google Scholar
• Czernik, P. J., Little, J. M., Barone, G. W., Raufman, J. P., Radominska-Pandya, A. (2000). Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyltransferase 2B7 in human intestinal mucosa. Drug Metab Dispos 28:1210–1216.
   PubMed Web of Science ®Google Scholar
• de Hoon, M., Hayashizaki, Y. (2008). Deep cap analysis gene expression (CAGE): genome-wide identification of promoters, quantification of their expression, and network inference. Biotechniques 44:627–628, 630, 632.
   PubMed Web of Science ®Google Scholar
• Dutton, G. J. (1980). Glucuronidation of drugs and other compounds. Boca Raton, Florida, USA: CRC Press.
   Google Scholar
• Finel, M., Kurkela, M. (2008). The UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70–76.
   PubMed Web of Science ®Google Scholar
• Fournel-Gigleux, S., Jackson, M. R., Wooster, R., Burchell, B. (1989). Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell culture. FEBS Lett 243:119–122.
   PubMed Web of Science ®Google Scholar
• Fremont, J. J., Wang, R. W., King, C. D. (2005). Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. Mol Pharmacol 67:260–262. [Epub 2004 Oct 14].
   PubMed Web of Science ®Google Scholar
• Fujiwara, R., Nakajima, M., Oda, S., Yamanaka, H., Ikushiro, S. I., Sakaki, T., et al. (2009). Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. J Pharm Sci 27:27.
   Google Scholar
• Fujiwara, R., Nakajima, M., Yamanaka, H., Katoh, M., and Yokoi, T. (2007a). Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities. Drug Metab Dispos 35:1781–1787. [Epub 2007 Jul 9].
   PubMed Web of Science ®Google Scholar
• Fujiwara, R., Nakajima, M., Yamanaka, H., Nakamura, A., Katoh, M., Ikushiro, S., et al. (2007b). Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab Dispos 35:747–757. [Epub 2007 Feb 9].
   PubMed Web of Science ®Google Scholar
• Gagne, J. F., Montminy, V., Belanger, P., Journault, K., Gaucher, G., Guillemette, C. (2002). Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 62:608–617.
   PubMed Web of Science ®Google Scholar
• Gagnon, J. F., Bernard, O., Villeneuve, L., Tetu, B., Guillemette, C. (2006). Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. Clin Cancer Res 12:1850–1858.
   PubMed Web of Science ®Google Scholar
• Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Coffman, B. L., et al. (1999a). Differential glucuronidation of bile acids, androgens, and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70(1–3):101–108.
   PubMed Web of Science ®Google Scholar
• Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Coffman, B. L., et al. (1999b). Differential glucuronidation of bile acids, androgens, and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70(1–3):101–108.
   PubMed Web of Science ®Google Scholar
• Gallagher, C. J., Kadlubar, F. F., Muscat, J. E., Ambrosone, C. B., Lang, N. P., Lazarus, P. (2008). The UGT2B17 gene deletion polymorphism and risk of prostate cancer: a case-control study in Caucasians. Cancer Detect Prev 32:186–187.
   Google Scholar
• Gardner-Stephen, D. A., Mackenzie, P. I. (2008). Liver-enriched transcription factors and their role in regulating UDP-glucuronosyltransferase gene expression. Curr Drug Metab 9:439–452.
   PubMed Web of Science ®Google Scholar
• Ghosh, S. S., Sappal, B. S., Kalpana, G. V., Lee, S. W., Chowdhury, J. R., Chowdhury, N. R. (2001). Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications. J Biol Chem 276:42108–42115.
   PubMed Web of Science ®Google Scholar
• Gilbert, W. (1978). Why genes in pieces? Nature 271:501.
   PubMed Web of Science ®Google Scholar
• Girard, H., Levesque, E., Bellemare, J., Journault, K., Caillier, B., Guillemette, C. (2007). Genetic diversity at the UGT1 locus is amplified by a novel 3’ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genom 17:1077–1089.
   PubMed Web of Science ®Google Scholar
• Gong, Q. H., Cho, J. W., Huang, T., Potter, C., Gholami, N., Basu, N. K., et al. (2001). Thirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357–368.
   PubMedGoogle Scholar
• Grady, W. M., Carethers, J. M. (2008). Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135:1079–1099. [Epub 2008 Sep 4].
   PubMed Web of Science ®Google Scholar
• Gregory, P. A., Lewinsky, R. H., Gardner-Stephen, D. A., Mackenzie, P. I. (2004). Regulation of UDP-glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199:354–363.
   PubMed Web of Science ®Google Scholar
• Guillemette, C. (2003). Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 3:136–158.
   PubMed Web of Science ®Google Scholar
• Guillemette, C., Belanger, A., Lepine, J. (2004). Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res 6:246–254. [Epub 2004 Sep 27].
   PubMed Web of Science ®Google Scholar
• Hashimoto, S., Chiorazzi, N., Gregersen, P. K. (1995). Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol 32:651–659.
   PubMed Web of Science ®Google Scholar
• Ikushiro, S., Emi, Y., Iyanagi, T. (1997). Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 36:7154–7161.
   PubMed Web of Science ®Google Scholar
• Innocenti, F., Liu, W., Fackenthal, D., Ramirez, J., Chen, P., Ye, X., et al. (2008). Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet Genomics 18:683–697.
   PubMed Web of Science ®Google Scholar
• Ishii, Y., Miyoshi, A., Watanabe, R., Tsuruda, K., Tsuda, M., Yamaguchi-Nagamatsu, Y., et al. (2001). Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation. Mol Pharmacol 60:1040–1048.
   PubMed Web of Science ®Google Scholar
• Jakobsson, J., Ekstrom, L., Inotsume, N., Garle, M., Lorentzon, M., Ohlsson, C., et al. (2006). Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687–693. [Epub 2005 Dec 6].
   PubMed Web of Science ®Google Scholar
• Jedlitschky, G., Cassidy, A. J., Sales, M., Pratt, N., Burchell, B. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340(Pt 3):837–843.
   PubMedGoogle Scholar
• Jin, C., Miners, J. O., Lillywhite, K. J., Mackenzie, P. I. (1993b). Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264:475–479.
   PubMed Web of Science ®Google Scholar
• Jin, C. J., Miners, J. O., Lillywhite, K. J., Mackenzie, P. I. (1993a). cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 194:496–503.
   PubMed Web of Science ®Google Scholar
• Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P. M., Armour, C. D., et al. (2003). Genomewide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141–2144.
   PubMed Web of Science ®Google Scholar
• Joshi, N., Johnson, L. L., Wei, W. Q., Abnet, C. C., Dong, Z. W., Taylor, P. R., et al. (2006). Gene-expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res 66:6851–6860.
   PubMed Web of Science ®Google Scholar
• Jude, A. R., Little, J. M., Bull, A. W., Podgorski, I., Radominska-Pandya, A. (2001). 13-hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases. Drug Metab Dispos 29:652–655.
   PubMed Web of Science ®Google Scholar
• Kampa, D., Cheng, J., Kapranov, P., Yamanaka, M., Brubaker, S., Cawley, S., et al. (2004). Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res 14:331–342.
   PubMed Web of Science ®Google Scholar
• Karypidis, A. H., Olsson, M., Andersson, S. O., Rane, A., Ekstrom, L. (2008). Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J 8:147–151.
   PubMed Web of Science ®Google Scholar
• King, C. D., Rios, G. R., Green, M. D., Tephly, T. R. (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1:143–161.
   PubMed Web of Science ®Google Scholar
• Kornblihtt, A. R. (2005). Promoter usage and alternative splicing. Curr Opin Cell Biol 17:262–268.
   PubMed Web of Science ®Google Scholar
• Kurkela, M., Garcia-Horsman, J. A., Luukkanen, L., Morsky, S., Taskinen, J., Baumann, M., et al. (2003). Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536–3544. [Epub 2002 Nov 14].
   PubMed Web of Science ®Google Scholar
• Kurkela, M., Hirvonen, J., Kostiainen, R., Finel, M. (2004). The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers. Biochem Pharmacol 68:2443–2450.
   PubMed Web of Science ®Google Scholar
• Kurkela, M., Patana, A. S., Mackenzie, P. I., Court, M. H., Tate, C. G., Hirvonen, J., et al. (2007). Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6. Pharmacogenet Genom 17:115–126.
   PubMed Web of Science ®Google Scholar
• Lepine, J., Bernard, O., Plante, M., Tetu, B., Pelletier, G., Labrie, F., et al. (2004). Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222–5232.
   PubMed Web of Science ®Google Scholar
• Levesque, E., Beaulieu, M., Green, M. D., Tephly, T. R., Belanger, A., Hum, D. W. (1997). Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317–325.
   PubMedGoogle Scholar
• Levesque, E., Beaulieu, M., Hum, D. W., Belanger, A. (1999). Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9:207–216.
   PubMedGoogle Scholar
• Levesque, E., Girard, H., Journault, K., Lepine, J., Guillemette, C. (2007). Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128–138.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Ménard, V., Bellemare, J., Girard, H., Guillemette, C. Extensive splicing of transcripts encoding the bile acid-;conjugating enzyme UGT2B4 modulates glucuronidation. Under review.
   Google Scholar
• Levesque, E., Turgeon, D., Carrier, J. S., Montminy, V., Beaulieu, M., Belanger, A. (2001). Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40:3869–3881.
   PubMed Web of Science ®Google Scholar
• Lin, L., Liu, S., Brockway, H., Seok, J., Jiang, P., Wong, W. H., et al. (2009). Using high-density exon arrays to profile gene expression in closely related species. Nucleic Acids Res 27:27.
   Google Scholar
• Lincz, L. F., Mudge, L. M., Scorgie, F. E., Sakoff, J. A., Hamilton, C. S., Seldon, M. (2008). Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia 10:1131–1137.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677–685.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., Lewinsky, R. H., Jorgensen, B. R., Nishiyama, T., et al. (2003). Regulation of UDP-glucuronosyltransferase genes. Curr Drug Metab 4:249–257.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Gregory, P. A., Lewinsky, R. H., Yasmin, S. N., Height, T., McKinnon, R. A., et al. (2005). Polymorphic variations in the expression of the chemical detoxifying UDP-glucuronosyltransferases. Toxicol Appl Pharmacol 207(2 Suppl):77–83.
   PubMedGoogle Scholar
• Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., et al. (1997). The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255–269.
   PubMedGoogle Scholar
• Maniatis, T., Tasic, B. (2002). Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418:236–243.
   PubMed Web of Science ®Google Scholar
• McCarroll, S. A., Hadnott, T. N., Perry, G. H., Sabeti, P. C., Zody, M. C., Barrett, J. C., et al. (2006). Common deletion polymorphisms in the human genome. Nat Genet 38:86–92.
   PubMed Web of Science ®Google Scholar
• McElvaine, A. T., Mayo, K. E. (2006). A dominant-negative human growth hormone–releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 147:1884–1894.
   PubMed Web of Science ®Google Scholar
• Meech, R., Mackenzie, P. I. (1997a). Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907–915.
   PubMed Web of Science ®Google Scholar
• Meech, R., Mackenzie, P. I. (1997b). UDP-glucuronosyltransferase, the role of the amino terminus in dimerization. J Biol Chem 272:26913–26917.
   PubMed Web of Science ®Google Scholar
• Meech, R., Mackenzie, P. I. (1998). Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum. Arch Biochem Biophys 356:77–85.
   PubMed Web of Science ®Google Scholar
• Menard, V., Eap, O., Harvey, M., Guillemette, C., Lévesque, E. (2009). Copy-number variations of the human sex steroid metabolizing genes, UGT2B17 and UGT2B28, along with their associations with a UGT2B15 functional polymorphism. Hum Mutat 30:1310–1319.
   PubMed Web of Science ®Google Scholar
• Moore, M. J., Proudfoot, N. J. (2009). Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136:688–700.
   PubMed Web of Science ®Google Scholar
• Murata, M., Warren, E. H., Riddell, S. R. (2003). A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 197:1279–1289.
   PubMed Web of Science ®Google Scholar
• Nakajima, M., Yamanaka, H., Fujiwara, R., Katoh, M., Yokoi, T. (2007). Stereoselective glucuronidation of 5-(4’-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactions. Drug Metab Dispos 35:1679–1686. [Epub 2007 Jun 18].
   PubMed Web of Science ®Google Scholar
• Nakamura, M., Hashimoto, T., Furuyama, J., Kakudo, K. (1995a). Multiple alternative splice isoforms of parathyroid hormone-related peptide mRNA in human cell lines. J Mol Endocrinol 15:245–249.
   PubMed Web of Science ®Google Scholar
• Nakamura, M., Hashimoto, T., Nakajima, T., Ichii, S., Furuyama, J., Ishihara, Y., et al. (1995b). A new type of human calcitonin receptor isoform generated by alternative splicing. Biochem Biophys Res Commun 209:744–751.
   PubMed Web of Science ®Google Scholar
• Olsson, M., Lindstrom, S., Haggkvist, B., Adami, H. O., Balter, K., Stattin, P., et al. (2008). The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 4:4.
   Google Scholar
• Operana, T. N., Tukey, R. H. (2007). Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation. J Biol Chem 282:4821–4829.
   PubMed Web of Science ®Google Scholar
• Ouzzine, M., et al. (1999). An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyl transferase 1A6 to the endoplasmic reticulum. J Biol Chem 274:31401–31409.
   PubMed Web of Science ®Google Scholar
• Ouzzine, M., Barre, L., Netter, P., Magdalou, J., Fournel-Gigleux, S. (2003). The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation. Drug Metab Rev 35:287–303.
   PubMed Web of Science ®Google Scholar
• Owens, I. S., Basu, N. K., Banerjee, R. (2005). UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Meth Enzymol 400:1–22.
   PubMed Web of Science ®Google Scholar
• Park, J., Chen, L., Ratnashinge, L., Sellers, T. A., Tanner, J. P., Lee, J. H., et al. (2006). Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African-American and Caucasian men. Cancer Epidemiol Biomark Prev 15:1473–1478.
   PubMed Web of Science ®Google Scholar
• Park, J., Chen, L., Shade, K., Lazarus, P., Seigne, J., Patterson, S., et al. (2004). Asp85tyr polymorphism in the UDP-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol 171(6 Pt 1):2484–2488.
   PubMed Web of Science ®Google Scholar
• Park, J. Y., Tanner, J. P., Sellers, T. A., Huang, Y., Stevens, C. K., Dossett, N., et al. (2007). Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70:374–379.
   PubMed Web of Science ®Google Scholar
• Passetti, F., Ferreira, C. G., Costa, F. F. (2009). The impact of micro-RNAs and alternative splicing in pharmacogenomics. Pharmacogenom J 9:1–13.
   PubMed Web of Science ®Google Scholar
• Patana, A. S., Kurkela, M., Goldman, A., Finel, M. (2007). The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site. Mol Pharmacol 72:604–611. [Epub 2007 Jun 19].
   PubMed Web of Science ®Google Scholar
• Pillot, T., Ouzzine, M., Fournel-Gigleux, S., Lafaurie, C., Radominska, A., Burchell, B., et al. (1993). Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 268:25636–25642.
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E., Mackenzie, P. I. (1999). Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817–899.
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya, A., Ouzzine, M., Fournel-Gigleux, S., Magdalou, J. (2005). Structure of UDP-glucuronosyltransferases in membranes. Meth Enzymol 400:116–147.
   PubMed Web of Science ®Google Scholar
• Ramirez, J., Mirkov, S., Zhang, W., Chen, P., Das, S., Liu, W., et al. (2008). Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9, and UGT2B7 mRNA expression in human liver. Pharmacogenom J 8:152–161. [Epub 2007 Apr 17].
   PubMed Web of Science ®Google Scholar
• Relton, C. L., Freathy, R. M., Ring, S. M., Groom, A., Gray, R., Hattersley, A. T., Frayling, T. M., Davey Smith, G. (2008). The influence of metabolic polymorphisms and smoking during pregnancy on fetal growth and preterm delivery. 58th Annual meeting of the Ameican Society for Human Genetics (ASHG), Philadelphia, Pennsylvania, November 11–15, 2008.
   Google Scholar
• Riedy, M., Wang, J. Y., Miller, A. P., Buckler, A., Hall, J., Guida, M. (2000). Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics 10:251–260.
   PubMedGoogle Scholar
• Ritter, J. K. (2000). Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129(1–2):171–193.
   PubMed Web of Science ®Google Scholar
• Ritter, J. K. (2007). Intestinal UGTs as potential modifiers of pharmacokinetics and biological responses to drugs and xenobiotics. Expert Opin Drug Metab Toxicol 3:93–107.
   PubMed Web of Science ®Google Scholar
• Ritter, J. K., Chen, F., Sheen, Y. Y., Lubet, R. A., Owens, I. S. (1992a). Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry 31:3409–3414.
   PubMed Web of Science ®Google Scholar
• Ritter, J. K., Chen, F., Sheen, Y. Y., Tran, H. M., Kimura, S., Yeatman, M. T., et al. (1992b). A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267:3257–3261.
   PubMed Web of Science ®Google Scholar
• Ritter, J. K., Crawford, J. M., Owens, I. S. (1991). Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem 266:1043–1047.
   PubMed Web of Science ®Google Scholar
• Samanta, M. P., Tongprasit, W., Stolc, V. (2007). In-depth query of large genomes using tiling arrays. Meth Mol Biol 377:163–174.
   PubMedGoogle Scholar
• Schulze, J. J., Lundmark, J., Garle, M., Skilving, I., Ekstrom, L., Rane, A. (2008). Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93:2500–2506.
   PubMed Web of Science ®Google Scholar
• Senekeo-Effenberger, K., Chen, S., Brace-Sinnokrak, E., Bonzo, J. A., Yueh, M. F., Argikar, U., et al. (2007). Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos 35:419–427. [Epub 2006 Dec 6].
   PubMed Web of Science ®Google Scholar
• Shelton, B. P., Misso, N. L., Shaw, O. M., Arthaningtyas, E., Bhoola, K. D. (2008). Epigenetic regulation of human epithelial cell cancers. Curr Opin Mol Ther 10:568–578.
   PubMed Web of Science ®Google Scholar
• Spielman, R. S., Bastone, L. A., Burdick, J. T., Morley, M., Ewens, W. J., Cheung, V. G. (2007). Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 39:226–231.
   PubMed Web of Science ®Google Scholar
• Stamm, S. (2008). Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283:1223–1227.
   PubMed Web of Science ®Google Scholar
• Starlard-Davenport, A., Lyn-Cook, B., Radominska-Pandya, A. (2008). Identification of UDP-glucuronosyltransferase 1A10 in nonmalignant and malignant human breast tissues. Steroids 73:611–620.
   PubMed Web of Science ®Google Scholar
• Strassburg, C. P., Kalthoff, S., Ehmer, U. (2008). Variability and function of family 1 uridine-5’-diphosphate glucuronosyltransferases (UGT1A). Crit Rev Clin Lab Sci 45:485–530.
   PubMed Web of Science ®Google Scholar
• Strassburg, C. P., Manns, M. P., Tukey, R. H. (1998). Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 273:8719–8726.
   PubMed Web of Science ®Google Scholar
• Strassburg, C. P., Nguyen, N., Manns, M. P., Tukey, R. H. (1998). Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 54:647–654.
   PubMed Web of Science ®Google Scholar
• Sugatani, J., Sueyoshi, T., Negishi, M., Miwa, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocorticoid receptor. Methods Enzymol 400:92–104.
   PubMed Web of Science ®Google Scholar
• Sztainberg, Y., Kuperman, Y., Issler, O., Gil, S., Vaughan, J., Rivier, J., et al. (2009). A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J.
   PubMed Web of Science ®Google Scholar
• Takeda, S., Ishii, Y., Iwanaga, M., Nurrochmad, A., Ito, Y., Mackenzie, P I., et al. (2009). Interaction of cytochrome P450 3A4 and UDP-glucuronosyltransferase 2B7: evidence for protein-protein association and possible involvement of CYP3A4 J-helix in the interaction. Mol Pharmacol 75:956–964. [Epub 2009 Jan 21].
   PubMed Web of Science ®Google Scholar
• Toide, K., Takahashi, Y., Yamazaki, H., Terauchi, Y., Fujii, T., Parkinson, A., et al. (2002). Hepatocyte nuclear factor-1-alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers. Drug Metab Dispos 30:613–615.
   PubMed Web of Science ®Google Scholar
• Trottier, J., Verreault, M., Grepper, S., Monte, D., Belanger, J., Kaeding, J., et al. (2006). Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology 44:1158–1170.
   PubMed Web of Science ®Google Scholar
• Tukey, R. H., Strassburg, C. P. (2000). Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616.
   PubMed Web of Science ®Google Scholar
• Tukey, R. H., Strassburg, C. P. (2001). Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 59:405–414.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Chouinard, S., Belanger, A. (2003). Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos 31:670–676.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Levesque, E., Beatty, B. G., Belanger, A., Hum, D. W. (2000). Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489–504.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Levesque, E., Hum, D. W., Belanger, A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778–787.
   PubMed Web of Science ®Google Scholar
• Verreault, M., Senekeo-Effenberger, K., Trottier, J., Bonzo, J. A., Belanger, J., Kaeding, J., et al. (2006). The liver X-receptor alpha controls hepatic expression of the human bile acid–glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44:368–378.
   PubMed Web of Science ®Google Scholar
• Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., et al. (2008). Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476.
   PubMed Web of Science ®Google Scholar
• Wang, W., Kwok, A. M., Chan, J. Y. (2007). The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol Chem 282:24670–24678.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Gerstein, M., Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57–63.
   PubMed Web of Science ®Google Scholar
• Wells, P. G., Mackenzie, P. I., Chowdhury, J. R., Guillemette, C., Gregory, P. A., Ishii, Y., et al. (2004). Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281–290.
   PubMed Web of Science ®Google Scholar
• Wilson, W., 3rd, Pardo-Manuel de Villena, F., Lyn-Cook, B. D., Chatterjee, P. K., Bell, T. A., Detwiler, D. A., et al. (2004). Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707–714.
   PubMed Web of Science ®Google Scholar
• Xue, Y., Sun, D., Daly, A., Yang, F., Zhou, X., Zhao, M., et al. (2008). Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet 83:337–346.
   PubMed Web of Science ®Google Scholar
• Yang, T. L., Chen, X. D., Guo, Y., Lei, S. F., Wang, J. T., Zhou, Q., et al. (2008). Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet 83:663–674. [Epub 2008 Nov 6].
   PubMed Web of Science ®Google Scholar
• Yuan, J. H., Li, Y. Q., Yang, X. Y. (2007). Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice. Pharmacology 80:269–278. [Epub 2007 Jul 26].
   PubMed Web of Science ®Google Scholar